ELEVAI Labs Inc
NASDAQ:ELAB
Profitability Summary
ELEVAI Labs Inc's profitability score is 19/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Score
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Score
Score
Margins
Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.
Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Earnings Waterfall
ELEVAI Labs Inc
|
Revenue
|
1.7m
USD
|
|
Operating Expenses
|
-5.4m
USD
|
|
Operating Income
|
-3.7m
USD
|
|
Other Expenses
|
-2.6m
USD
|
|
Net Income
|
-6.2m
USD
|
Margins Comparison
ELEVAI Labs Inc Competitors
| Country | Company | Market Cap |
Operating Margin |
Net Margin |
||
|---|---|---|---|---|---|---|
| US |
E
|
ELEVAI Labs Inc
NASDAQ:ELAB
|
3.2m USD |
-209%
|
-357%
|
|
| US |
|
Kenvue Inc
NYSE:KVUE
|
39.8B USD |
17%
|
7%
|
|
| BR |
|
Natura &Co Holding SA
OTC:NTCOY
|
7.7B USD |
4%
|
-30%
|
|
| CN |
M
|
Mao Geping Cosmetics Co Ltd
HKEX:1318
|
49.4B HKD |
30%
|
23%
|
|
| KR |
A
|
APR Co Ltd
KRX:278470
|
6T KRW |
18%
|
16%
|
|
| IL |
O
|
Oddity Tech Ltd
NASDAQ:ODD
|
4.2B USD |
17%
|
15%
|
|
| KY |
H
|
Herbalife Ltd
XMUN:HOO
|
2.8B EUR |
12%
|
6%
|
|
| KR |
d
|
d'Alba Global Co Ltd
KRX:483650
|
2.8T KRW | N/A | N/A | |
| CN |
|
Runben Biotechnology Co Ltd
SSE:603193
|
12B CNY |
23%
|
23%
|
|
| IN |
H
|
Honasa Consumer Ltd
NSE:HONASA
|
98.1B INR |
1%
|
4%
|
|
| CN |
D
|
Dencare Chongqing Oral Care Co Ltd
SZSE:001328
|
7.9B CNY |
11%
|
11%
|
Return on Capital
Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.
Return on Capital Comparison
ELEVAI Labs Inc Competitors
| Country | Company | Market Cap | ROE | ROA | ROCE | ROIC | ||
|---|---|---|---|---|---|---|---|---|
| US |
E
|
ELEVAI Labs Inc
NASDAQ:ELAB
|
3.2m USD |
-119%
|
-88%
|
-66%
|
-126%
|
|
| US |
|
Kenvue Inc
NYSE:KVUE
|
39.8B USD |
10%
|
4%
|
13%
|
8%
|
|
| BR |
|
Natura &Co Holding SA
OTC:NTCOY
|
7.7B USD |
-49%
|
-24%
|
5%
|
-19%
|
|
| CN |
M
|
Mao Geping Cosmetics Co Ltd
HKEX:1318
|
49.4B HKD |
25%
|
20%
|
33%
|
56%
|
|
| KR |
A
|
APR Co Ltd
KRX:278470
|
6T KRW |
43%
|
27%
|
40%
|
40%
|
|
| IL |
O
|
Oddity Tech Ltd
NASDAQ:ODD
|
4.2B USD |
32%
|
20%
|
34%
|
51%
|
|
| KY |
H
|
Herbalife Ltd
XMUN:HOO
|
2.8B EUR |
-32%
|
11%
|
35%
|
35%
|
|
| KR |
d
|
d'Alba Global Co Ltd
KRX:483650
|
2.8T KRW | N/A | N/A | N/A | N/A | |
| CN |
|
Runben Biotechnology Co Ltd
SSE:603193
|
12B CNY |
14%
|
14%
|
15%
|
36%
|
|
| IN |
H
|
Honasa Consumer Ltd
NSE:HONASA
|
98.1B INR |
6%
|
4%
|
2%
|
3%
|
|
| CN |
D
|
Dencare Chongqing Oral Care Co Ltd
SZSE:001328
|
7.9B CNY |
9%
|
6%
|
8%
|
23%
|
Free Cash Flow
Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.
If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.
You don't have any saved screeners yet
